Neuroprotective effect of TREM-2 in aging and Alzheimer's disease model

Journal of Alzheimer's Disease

Volumn 55, Issue 1, 2016, Pages 199-217

  Raha, Animesh Alexander ^a   Henderson, James W ^a   Stott, Simon R W ^a   Vuono, Romina ^a   Foscarin, Simona ^a   Friedland, Robert P ^b   Zaman, Shahid H ^c   Raha Chowdhury, Ruma ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Alzheimer' disease; choroid plexus macrophages; immunomodulation; innate immunity; myelination; neurogenesis; neuroinflammation; neuroplasticity; neuroprotective; soluble TREM2

Indexed keywords

LIPOPOLYSACCHARIDE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; AMYLOID PRECURSOR PROTEIN; APP PROTEIN, HUMAN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; MESSENGER RNA; PRESENILIN 1; PSEN1 PROTEIN, HUMAN;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELL SURVIVAL; CHOROID PLEXUS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; ENDOSOME; GLIA CELL; GOLGI COMPLEX; HEART VENTRICLE WALL MOTION; MACROPHAGE; MOUSE; MYELINATION; NERVE CELL; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; GENETICS; HUMAN; MENINX; METABOLISM; MICROGLIA; PATHOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CELLS, CULTURED; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MENINGES; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; NEUROGENESIS; NEURONS; NEUROPROTECTION; PRESENILIN-1; RATS, SPRAGUE-DAWLEY; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER;

EID: 84994662295     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160663     Document Type: Article

References (64)

1. Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (1998) Genetic dissection of Alzheimer?s disease and related dementias: Amyloid and its relationship to tau. Nat Neurosci 1, 355-358.
2. Selkoe DJ, Bell DS, Podlisny MB, Price DL, Cork LC (1987) Conservation of brain amyloid proteins in agedmammals and humans with Alzheimer?s disease. Science 235, 873-877.
3. Kim YS, Joh TH (2006) Microglia, major player in the brain inflammation: Their roles in the pathogenesis of Parkinson?s disease. Exp Mol Med 38, 333-347.
4. Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson?s disease. Br J Pharmacol 150, 963-976.
5. Hirsch EC, Vyas S, Hunot S (2012) Neuroinflammation in Parkinson?s disease. Parkinsonism Relat Disord 18(Suppl 1), S210-S212.
6. Moller T (2010) Neuroinflammation in Huntington?s disease. J Neural Transm (Vienna) 117, 1001-1008.
7. Holmoy T (2008) T cells in amyotrophic lateral sclerosis. Eur J Neurol 15, 360-366.
8. Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis-The plaque and its pathogenesis. N Engl J Med 354, 942-955.
9. Engelhardt B (2008) The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des 14, 1555-1565.
10. Raha AA, Bomford A, Raha-Chowdhury R (2013) Hepcidin and ferroportin participate in iron clearance from brain endothelium: Failure of this process leads to iron accumulation in Alzheimer?s disease. Am J Hematol 88, E156-E156.
11. Schwartz M, Kipnis J (2005) Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J Neurol Sci 233, 163-166.
12. Town T, Nikolic V, Tan J (2005) The microglial "activation" continuum: From innate to adaptive responses. J Neuroinflammation 2, 24.
13. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer?s disease. Trends Pharmacol Sci 12, 383-388.
14. Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12, 609-622.
15. Walsh DM, Selkoe DJ (2004) Oligomers on the brain: The emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11, 213-228.
16. Raha AA, Vaishnav RA, Friedland RP, Bomford A, Raha-Chowdhury R (2013) The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer?s disease. Acta Neuropathol Commun 1, 55.
17. Daws MR, Lanier LL, Seaman WE, Ryan JC (2001) Cloning and characterization of a novel mouse myeloid DAP12-Associated receptor family. Eur J Immunol 31, 783-791.
18. Cannon JP, O'Driscoll M, Litman GW (2012) Specific lipid recognition is a general feature of CD300 and TREM molecules. Immunogenetics 64, 39-47.
19. Guerreiro R, Hardy J (2013) TREM2and neurodegenerative disease. N Engl J Med 369, 1569-1570.
20. Jonsson T, Stefansson K (2013) TREM2 and neurodegenerative disease. N Engl J Med 369, 1568-1569.
21. Tanzi RE (2015) TREM2 and risk of Alzheimer?s disease-friend or foe? N Engl J Med 372, 2564-2565.
22. Slattery CF, Beck JA, Harper L, Adamson G, Abdi Z, Uphill J, Campbell T, Druyeh R, Mahoney CJ, Rohrer JD, Kenny J, Lowe J, Leung KK, Barnes J, Clegg SL, Blair M, Nicholas JM, Guerreiro RJ, Rowe JB, Ponto C, Zerr I, Kretzschmar H, Gambetti P, Crutch SJ, Warren JD, Rossor MN, Fox NC, Collinge J, Schott JM, Mead S (2014) R47HTREM2variant increases risk of typical early-onset Alzheimer?s disease but not of prion or frontotemporal dementia. Alzheimers Dement 10, 602-608 e604.
23. Hsieh CL, Koike M, Spusta SC, Niemi EC, Yenari M, Nakamura MC, Seaman WE (2009) A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia. J Neurochem 109, 1144-1156.
24. Kleinberger G, Yamanishi Y, Suarez-Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger-Weinzierl A, Mazaheri F, Tahirovic S, Lleo A, Alcolea D, Fortea J, Willem M, Lammich S, Molinuevo JL, Sanchez-Valle R, Antonell A, Ramirez A, Heneka MT, Sleegers K, van der Zee J, Martin JJ, Engelborghs S, Demirtas-Tatlidede A, Zetterberg H, Van Broeckhoven C, Gurvit H, Wyss-Coray T, Hardy J, Colonna M, Haass C (2014) TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med 6, 243ra286.
25. Frank S, Burbach GJ, Bonin M, Walter M, Streit W, Bechmann I, Deller T (2008) TREM2is upregulated in amyloid plaque-Associated microglia in aged APP23 transgenic mice. Glia 56, 1438-1447.
26. Kiialainen A, Hovanes K, Paloneva J, Kopra O, Peltonen L (2005) Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS. Neurobiol Dis 18, 314-322.
27. Humphrey MB, Daws MR, Spusta SC, Niemi EC, Torchia JA, Lanier LL, Seaman WE, Nakamura MC (2006) TREM2, a DAP12-Associated receptor, regulates osteoclast differentiation and function. J Bone Miner Res 21, 237-245.
28. Satoh J, Kawana N, Yamamoto Y, Ishida T, Saito Y, Arima K (2013) A survey of TREM2 antibodies reveals neuronal but not microglial staining in formalin-fixed paraffin-embedded postmortem Alzheimer?s brain tissues. Alzheimers Res Ther 5, 30.
29. Poliani PL, Wang Y, Fontana E, Robinette ML, Yamanishi Y, Gilfillan S, Colonna M (2015) TREM2 sustains microglial expansion during aging and response to demyelination. J Clin Invest 125, 2161-2170.
30. Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, Bianchin M, Bird T, Miranda R, Salmaggi A, Tranebjaerg L, Konttinen Y, Peltonen L (2002) Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet 71, 656-662.
31. Thrash JC, Torbett BE, Carson MJ (2009) Developmental regulation of TREM2 and DAP12 expression in the murine CNS: Implications for Nasu-Hakola disease. Neurochem Res 34, 38-45.
32. Xing J, Titus AR, Humphrey MB (2015) The TREM2-DAP12 signaling pathway in Nasu-Hakola disease: A molecular genetics perspective. Res Rep Biochem 5, 89-100.
33. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
34. Ashe KH (2001) Learning and memory in transgenic mice modeling Alzheimer?s disease. Learn Mem 8, 301-308.
35. Kumar-Singh S, Pirici D, McGowan E, Serneels S, Ceuterick C, Hardy J, Duff K, Dickson D, Van Broeckhoven C (2005) Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer?s disease are centered on vessel walls. Am J Pathol 167, 527-543.
36. Ulrich JD, Finn MB, Wang Y, Shen A, Mahan TE, Jiang H, Stewart FR, Piccio L, Colonna M, Holtzman DM (2014) Altered microglial response to Abeta plaques in APPPS1-21 mice heterozygous for TREM2. Mol Neurodegener 9, 20.
37. Frautschy SA, Yang F, Irrizarry M, Hyman B, Saido TC, Hsiao K, Cole GM (1998) Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol 152, 307-317.
38. Jay TR, Miller CM, Cheng PJ, Graham LC, Bemiller S, Broihier ML, Xu G, Margevicius D, Karlo JC, Sousa GL, Cotleur AC, Butovsky O, Bekris L, Staugaitis SM, Leverenz JB, Pimplikar SW, Landreth GE, Howell GR, Ransohoff RM, Lamb BT (2015) TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer?s disease mouse models. J Exp Med 212, 287-295.
39. Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S, Zinselmeyer BH, Holtzman DM, Cirrito JR, Colonna M (2015) TREM2 lipid sensing sustains the microglial response in an Alzheimer?s disease model. Cell 160, 1061-1071.
40. Raha-Chowdhury R, Raha AA, Forostyak S, Zhao JW, Stott SRW, Bomford A (2015) Expression and cellular localization of hepcidin mRNA and protein in normal rat brain. BMC Neurosci 16, 24.
41. Raha-Chowdhury R, Andrews SR, Gruen JR (2005) CAT 53: A protein phosphatase 1 nuclear targeting subunit encoded in the MHC Class I region strongly expressed in regions of the brain involved in memory, learning, and Alzheimer?s disease. Mol Brain Res 138, 70-83.
42. Marland JR, Pan D, Buttery PC (2011) Rac GTPaseactivating protein (Rac GAP) alpha1-Chimaerin undergoes proteasomal degradation and is stabilized by diacylglycerol signaling in neurons. J Biol Chem 286, 199-207.
43. Goncalves LA, Rodrigues-Duarte L, Rodo J, Vieira de Moraes L, Marques I, Penha-Goncalves C (2013) TREM2 governs Kupffer cell activation and explains belr1 genetic resistance to malaria liver stage infection. Proc Natl Acad Sci U S A 110, 19531-19536.
44. Otero K, Shinohara M, Zhao H, Cella M, Gilfillan S, Colucci A, Faccio R, Ross FP, Teitelbaum SL, Takayanagi H, Colonna M (2012) TREM2 and beta-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis. J Immunol 188, 2612-2621.
45. Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: The role of inflammation in Alzheimer disease. Nat Rev Neurosci 16, 358-372.
46. Lill CM, Rengmark A, Pihlstrom L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J, Partch A, Restagno G, Rujescu D, Schnack C, Shaw CE, Shaw PJ, Tumani H, Tysnes OB, Valladares O, Silani V, van den Berg LH, van Rheenen W, Veldink JH, Lindenberger U, Steinhagen-Thiessen E, Consortium S, Teipel S, Perneczky R, Hakonarson H, Hampel H, von Arnim CA, Olsen JH, Van Deerlin VM, Al-Chalabi A, Toft M, Ritz B, Bertram L (2015) The role of TREM2 R47H as a risk factor for Alzheimer?s disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson?s disease. Alzheimers Dement 11, 1407-1416.
47. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi BV, Jacobson KA, Kohsaka S, Inoue K (2007) UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446, 1091-1095.
48. Sierra A, Encinas JM, Deudero JJ, Chancey JH, Enikolopov G, Overstreet-Wadiche LS, Tsirka SE, Maletic-Savatic M (2010) Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7, 483-495.
49. Costello DA, Keenan K, McManus RM, Falvey A, Lynch MA (2016) The age-related neuroinflammatory environment promotes macrophage activation, which negatively impacts synaptic function. Neurobiol Aging 43, 140-148.
50. Forabosco P, Ramasamy A, Trabzuni D, Walker R, Smith C, Bras J, Levine AP, Hardy J, Pocock JM, Guerreiro R, Weale ME, Ryten M (2013) Insights into TREM2 biology by network analysis of human brain gene expression data. Neurobiol Aging 34, 2699-2714.
51. Lampron A, Pimentel-Coelho PM, Rivest S (2013) Migration of bone marrow-derived cells into the central nervous system in models of neurodegeneration. J Comp Neurol 521, 3863-3876.
52. Gate D, Rezai-Zadeh K, Jodry D, Rentsendorj A, Town T (2010) Macrophages in Alzheimer?s disease: The bloodborne identity. J Neural Transm (Vienna) 117, 961-970.
53. Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, Nahaboo Solim MA, Moens TG, Paublete RM, Ali SS, Perona M, Desai R, Smith KJ, Latcham J, Fulleylove M, Richardson JC, Hardy J, Edwards FA (2015) A genomewide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep 10, 633-644.
54. Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, Yuan P, Mahan TE, Shi Y, Gilfillan S, Cella M, Grutzendler J, DeMattos RB, Cirrito JR, Holtzman DM, Colonna M (2016) TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J Exp Med 213, 667-675.
55. Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, Luo W, Colonna M, Baddeley D, Grutzendler J (2016) TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron 90, 724-739.
56. Sessa G, Podini P, Mariani M, Meroni A, Spreafico R, Sinigaglia F, Colonna M, Panina P, Meldolesi J (2004) Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia. Eur J Neurosci 20, 2617-2628.
57. Prada I, Ongania GN, Buonsanti C, Panina-Bordignon P, Meldolesi J (2006) Triggering receptor expressed in myeloid cells 2 (TREM2) trafficking in microglial cells: Continuous shuttling to and from the plasma membrane regulated by cell stimulation. Neuroscience 140, 1139-1148.
58. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G (1996) Immune and inflammatory responses in TNF alphadeficient mice: A critical requirement for TNF alpha in the formation of primary Bcell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 184, 1397-1411.
59. Beaulieu LM, Lin E, Mick E, Koupenova M, Weinberg EO, Kramer CD, Genco CA, Tanriverdi K, Larson MG, Benjamin EJ, Freedman JE (2014) Interleukin 1 receptor 1 and interleukin 1beta regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol 34, 552-564.
60. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW (2006) Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392.
61. Nguyen MD, Julien JP, Rivest S (2002) Innate immunity: The missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3, 216-227.
62. Kipnis J, Schwartz M (2005) Controlled autoimmunity in CNS maintenance and repair: Naturally occurring CD4+CD25+ regulatory T-Cells at the crossroads of health and disease. Neuromolecular Med 7, 197-206.
63. Guillot-Sestier MV, Doty KR, Gate D, Rodriguez J, Jr, Leung BP, Rezai-Zadeh K, Town T (2015) Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology. Neuron 85, 534-548.
64. Guillot-Sestier MV, Doty KR, Town T (2015) Innate immunity fights Alzheimer?s disease. Trends Neurosci 38, 674-681.